COVID-19: CDC, FDA and CMS Guidance
This page includes AHA Today stories and other AHA content on coronavirus COVID-19 guidance from the CDC, FDA, and CMS.
The Food and Drug Administration (FDA) released a document this week to help accelerate the development of prevention and treatment options for COVID-19.
The Centers for Medicare and Medicaid Services (CMS) continues to release waivers to provide health care organizations with flexibility to respond to the COVID-19 public health emergency.
A recent advisory from the American Hospital Association (AHA) compiles useful information on maternal and neonatal practices during COVID-19 from government agencies, academic institutions, professional associations and health care organizations.
Given the impracticality of continuously testing people diagnosed with COVID-19 to determine whether they remain infectious, the Centers for Disease Control and Prevention (CDC) issued guidance this week on a symptom-based strategy for discontinuing isolation of persons with COVID-19.
The Centers for Medicare & Medicaid Services (CMS) this week announced regulations requiring nursing homes to fully cooperate with Centers for Disease Control and Prevention (CDC) surveillance of the spread of COVID-19 by reporting cases of COVID-19 directly to the CDC.
The Centers for Disease Control and Prevention (CDC) is now reporting national data on confirmed COVID-19 cases by both race and ethnicity.